System And Method For Reducing The Placebo Effect In Controlled Clinical Trials

Abstract

A method and system for performing a clinical trial having a reduced placebo effect is disclosed. The method includes randomizing study participants into three or more treatment groups and performing a first phase of testing on the groups. In a typical embodiment, the first phase of testing includes administering an active treatment to a first group, and administering a placebo to a second group and to a third group. Responders and non-responders are determined for each group. A second phase of testing is then performed. The second phase of testing includes administering the placebo to non-responders in the first group, administering the active treatment to non-responders in the second group, and administering the placebo to non-responders in the third group. The data from the first phase of testing and from the second phase of testing is pooled and analyzed to determine response rates to active treatment and placebo.


Claims
Download PDF
Document Preview
Document History
  • Publication: Jul 10, 2012
  • Application: Feb 23, 2012
    US US 201213403060 A
  • Priority: Feb 23, 2012
    US US 201213403060 A
  • Priority: Jul 5, 2011
    US US 201113176091 A
  • Priority: Jun 9, 2011
    US US 201113156481 A
  • Priority: Oct 21, 2010
    US US 90907510 A
  • Priority: Aug 21, 2009
    US US 54556209 A
  • Priority: Mar 31, 2004
    US US 81485204 A
  • Priority: Mar 31, 2003
    US US 45951703 P

Download Citation


Sign in to the Lens

Feedback